Drreddys Laboratories | RDY - Ordinary Share Capital



Drreddys Laboratories reported INR832.37M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
ANI Pharmaceuticals USD 2K 0 Mar/2025
Aurora Cannabis CAD 56.25M 6.92B Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Canopy Growth CAD 205.15M 8.47B Jun/2025
Cipla INR 1.62B 100K Mar/2025
Corcept Therapeutics USD 105.29M 105.15M Jun/2025
Drreddys Laboratories INR 832.37M 1.63M Jun/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Lonza CHF 72M 0 Dec/2024
Novartis USD 793M 0 Dec/2024
Pacira USD 44.9M 44.85M Jun/2025
Prestige Brands USD 49.21M 48.65M Jun/2025
Richter Gedeon HUF 18.64B 0 Dec/2024
Sun Pharmaceuticals INR 2.4B 0 Mar/2025
Supernus Pharmaceuticals USD 56.12M 130K Jun/2025
Teva Pharmaceutical Industries USD 1.15B 1.09B Jun/2025